Attuned to the burdens of people living with Huntington’s disease (HD) chorea and tardive dyskinesia (TD), Teva has been eager to cut the amount of pills patients need to take in half. Now, it's ...

No-moat Teva TEVA reported second-quarter earnings that were slightly ahead of our expectations. Total sales were up 2.4% year over year, driven by strong performance from Teva’s key innovative ...

Austedo XR is a vesicular monoamine transporter 2 inhibitor. The Food and Drug Administration (FDA) has approved Austedo ® XR, a new once-daily formulation of deutetrabenazine, for the treatment of ...

(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), said that the U.S. Food and Drug Administration has approved AUSTEDO XR as a one pill, once-daily ...

Please provide your email address to receive an email when new articles are posted on . Austedo treatment appeared to improve involuntary movements and quality of life among older adults with tardive ...

Deutetrabenazine 6mg, 12mg, 18mg, 24mg, 30mg, 36mg, 42mg, 48mg; ext-rel tabs. Swallow whole. Take with or without food. Individualize. Initially 12mg once daily; may titrate at weekly intervals by 6mg ...

The logo of Teva Pharmaceutical Industries is seen during a news conference in Tel Aviv (Reuters) -Teva Pharmaceutical Industries' drug Austedo should reach sales of $2.5 billion by 2027, Chief ...

On Wednesday, Teva Pharmaceutical Industries Ltd (NYSE:TEVA) reported second-quarter 2024 sales of $4.16 billion, beating the consensus of $4.06 billion. Revenues increased 7% year-over-year and 11% ...

23 abstracts appeared in the 2020 American Academy of Neurology (AAN) Science Highlights Supplement The abstracts were originally planned for presentation at the recently cancelled 2020 American ...

Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR ® (deutetrabenazine) extended-release tablets Patients reported ...

Please provide your email address to receive an email when new articles are posted on . Austedo was generally well tolerated among children and adolescents with Tourette syndrome; however, the ...